Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study

OBJECTIVES: Angiotensin II receptor blockers (ARBs) improve the survival rates of patients with various cancers. However, it remains unclear whether ARBs confer a survival benefit on patients with oral squamous cell carcinoma (OSCC). Here, we assessed the associations between ARB use and survival in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ching-Nung, Wu, Shao-Chun, Chen, Wei-Chih, Yang, Yao-Hsu, Chin, Jo-Chi, Chien, Chih-Yen, Fang, Fu-Min, Li, Shau-Hsuan, Luo, Sheng-Dean, Chiu, Tai-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638984/
https://www.ncbi.nlm.nih.gov/pubmed/34855858
http://dx.doi.org/10.1371/journal.pone.0260772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638984/
https://www.ncbi.nlm.nih.gov/pubmed/34855858
http://dx.doi.org/10.1371/journal.pone.0260772

Ejemplares similares